Clinical Trial Details


Research Study Summary

A Phase III, randomized, double-blind, placebo-controlled trial in patients with Ankylosing Spondylitis (AS).


24-Week trial comparing treatment with Study Medicine vs. placebo.

Patient Inclusion Criteria:

  • Age >/= 18
  • Diagnosis of definite AS
  • Active AS
  • Inadequate response to treatment.

Patient Exclusion Criteria:

  • Major Surgery within 8 weeks prior to screening
  • Inflammatory Disease other than AS
  • Treatment with Investigational Medication within 4 weeks
  • Hepatitis B, C, or HIV

To Learn more

CW ID: 165441
Date Last Changed: July 23, 2013

Clinical Trial Snapshot

Both Male and Female
18 and up
Overall Status
24 Weeks
Facility Type


Suzi DeFiesta, Research Administrator
CSI Research Inc
11379 Southbridge Parkway, Suite B
Alpharetta, GA 30022
Phone: 770-667-0220
Fax: 770-667-0227

View Map

Research Center Information:

CSI Research Inc

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.